MEIS1 and ovarian cancer: These findings are consistent with previous studies that demonstrated the involvement of HoxB5 and HoxA9 in ovarian cancer and it has similarly been reported that Hoxa9 and Meis1 cooperatively induce malignancy, and AML in particular35–37.